IRVING, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services company that exclusively serves premier oral and maxillofacial surgeons – has formed a new ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat) once-daily oral tablet for treatment of ...